Billerica, MA 5/25/17—US-based Pion, which provides analytical instruments for drug development, has acquired UK-based Sirius Analytical Instruments, which supplies testing instrumentation to the pharmaceutical industry. Financial details were not disclosed. “The combination of these two companies, with such deep roots in the drug development process, will have immediate impact across the industry,” commented Pion President Mike Kelly. “With a strategy of innovation and support, Pion firmly establishes themselves as the instrumentation leader for physical chemical property measurement.”

The combined company will have approximately 50 employees, according to a Pion spokesperson. She told IBO that no final decision has been made yet about whether Sirius Analytical products will be rebranded. Both companies provide solutions for drug formulation testing and development. Pion offers solutions for measuring dissolution, solubility, permeability, ionization and absorption. Similarly, Sirius Analytical offers products for determining solubility, dissolution and absorption, and also provides systems for particle-size measurement and injection testing. Both companies offer testing services as well.